Ardian buys 60% stake in Dedalus

The transaction saw the company's chair and CEO Giorgio Moretti selling his 10.41% stake through his Health Holding Company. Three Hills Capital Partners exited its 14% stake in the business and Mandarin Capital Partners sold its 35.59% stake.

As part of the deal, Moretti will retain the remaining 40% in the business and remain the company's CEO.

According to a statement, the company intends to use the fresh capital to strengthen its international expansion through further acquisitions and boost its product development programme.

Dedalus is deploying an acquisitions plan that included 40 transactions during the last five years, the latest being the acquisition of an 83% stake in listed Italian competitor NoemaLife.

Company
Established in 1990 and headquartered in Florence, Dedalus develops software focusing on the clinical healthcare sector.

The company employs 1,700 people and has a presence in 25 countries across Europe, the Middle East, North and South America, Africa and Asia. The business expects to post a turnover of €170m in 2016.

People
Ardian – Yann Chareton (managing director).
Dedalus – Giorgio Moretti (chair, CEO).

Advisers
Equity – Deloitte (corporate finance); Giovannelli e Associati (legal); KPMG (financial due diligence); CBA Studio Tributario (tax).
Company – DVR Capital (financial due diligence); BNP Paribas (corporate finance); Eversheds (legal); Gianni Origoni Grippo Cappelli & Partners (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Exits
• Technology
• Southern Europe
• Italy
• Ardian (formerly Axa PE)
• Secondary buyout